Stock ideas for May 6, 2013

Posted By:
Subscribe to GoodReturns

Stock ideas for May 6, 2013
Here are a few stock ideas from leading brokerage houses in the country.

Godrej Consumer Products

Ventura has recommended hold rating on Godrej Consumer Products  (GCPL), in its May 03, 2013 research report. The research firm expects, the company to post robust set of numbers in its domestic business going ahead on the back of new launches and increased A&P spends, continued distribution synergies and its focus in crème format.

During the quarter, GCPL launched a disruptive innovation in HI category (HIT Anti Roach Gel). Moreover, Godrej Consumer Products Ltd (GCPL) has displayed its consistency by clocking double digit revenue growth. We expect GCPL to post robust set of numbers in its domestic business going ahead on the back of new launches and increased A&P spends, continued distribution synergies and its focus in crème format (under hair colours category). In the international business, integration of operations in Africa and Argentina is expected to bring synergies over the next few quarters.

Gujarat Pipavav Port

GEPL Capital is bullish on Gujarat Pipavav Port  and has recommended buy rating on the stock with a target price of Rs 70 in its May 03, 2013 research report.

"Gujarat Pipavav Port, in Q1CY13, GPPL reported 24 percent y-o-y growth in total revenues to Rs 1,245 mn as compared to Rs 1,004 mn in Q1CY12. Container volumes for the Q1CY13 witnessed a marginal drop of 2 percent y-o-y to 161,000 TEUs as compared to 165,000 TEUs in Q1CY12, however, on sequential basis the volume increased by 3 percen

Sanofi India

Angel Broking has maintained a neutral rating on Sanofi India  in its April 30, 2013 research report. The research firm expects the net sales to post a 13.3 percent CAGR to Rs 1,917cr and EPS to register a 13.4 percent CAGR to Rs 99.1 over CY201214.

"For 1QCY2013, Sanofi India reported results lower than expectations, both the on top-and bottom-line fronts. Sales grew by 12.5 percent yoy; however the net profit grew by just 10.5 percent yoy, due to lower-than-expected OPM. Sanofi's net sales grew by 12.5 percent yoy to Rs 363cr for 1QCY2013, lower than our estimate of Rs 401cr. 

IDFC

AnandRathi is bullish on IDFC  and has recommendation buy rating on the stock with a target price of Rs 198 in its May 02, 2013 research report.

"IDFC's 4QFY13 loan growth was modest (15.7 percent yoy, 4.5 qoq), with approvals and disbursements falling 24 percent and 22 percent respectively. Exposure to the energy and transportation sectors slipped to 65.1 percent (66.1 percent in 4QFY12). Spreads were stable qoq at 2.5 percent, resulting in NII rising 9.9 percent yoy (-2 percent qoq). We expect NII to grow 22.1 percent in FY14 and 26 percent in FY15, led by the sturdy loan pipeline and IDFC's ability to manage spreads efficiently.

GoodReturns.in

DISCLAIMER: GoodReturns provides you with information covering shares, futures and options based on broker's reports as stated on various media. Investors are, however, warned that they should NOT take any buy or sell decision based on these views expressed in the article. Investors should consult their own financial and share advisors before taking purchase or sale decisions. GoodReturns does not take any responsibility for any losses incurred by investors who take their cues from the above article.

Read more about: stock picks
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'